Information for international stakeholders

The Danish Vasculitis Cohort Study (DANIVAS) is a national, prospective, observational multicenter study focused on patients with Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR). The primary aim of the study is to reduce disease- and treatment-related damage in GCA and PMR by enhancing disease control.

The study collects clinical data, patient-reported outcomes, and biobank samples for as long as patients are managed in rheumatology departments. A key objective is to assess whether advanced diagnostic imaging modalities can facilitate disease stratification and predict treatment requirements and complications at the individual patient level.

Furthermore, the systematic collection of prospective clinical data and biobank samples serves as a foundation for future research projects and international collaborations.

Future research fields could include differentiating the disease course, investigating treatment efficacy and treatment-related side effects, and examining comorbidities and complications arising from the disease or its management. Additionally, the study could support the identification of risk factors and biomarkers for disease progression and associated complications.

Interested in collaboration? Contact the steering committee at auh.danivas@rm.dk

Interested in learning more: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2024.1415076/full